Published in J Antimicrob Chemother on August 01, 2000
Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev (2005) 15.72
Extended-spectrum-beta-lactamase, AmpC, and Carbapenemase issues. J Clin Microbiol (2010) 3.58
Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002. J Clin Microbiol (2006) 2.06
Expert systems in clinical microbiology. Clin Microbiol Rev (2011) 1.07
Prevalence of extended-spectrum beta-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001. Antimicrob Agents Chemother (2003) 1.07
Cefepime in vitro activity against derepressed extended-spectrum beta-lactamase (ESBL)-producing and non-ESBL-producing Enterobacter cloacae by a disc diffusion method. J Antimicrob Chemother (2001) 0.81
Increased cefepime MIC for enterobacteriacae clinical isolates. Caspian J Intern Med (2013) 0.77
Randomised trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarction. Lancet (1997) 4.65
Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. Proc Natl Acad Sci U S A (1999) 2.87
Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis (1995) 2.59
Environmental risk factors for REM sleep behavior disorder: a multicenter case-control study. Neurology (2012) 2.54
Community-acquired meticillin-resistant Staphylococcus aureus in Australia. Australian Group on Antimicrobial Resistance. Lancet (1998) 2.08
Evaluation of CHROMagar Orientation for differentiation and presumptive identification of gram-negative bacilli and Enterococcus species. J Clin Microbiol (1996) 1.99
Prevalence of Bartonella henselae bacteremia, the causative agent of cat scratch disease, in an Australian cat population. Pathology (1996) 1.82
The Canadian Neurological Scale: validation and reliability assessment. Neurology (1989) 1.78
Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain (1998) 1.68
Multiple sclerosis and antecedent infections: a case-control study. Neurology (2000) 1.66
Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials. Dement Geriatr Cogn Disord (2001) 1.55
Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis. Ann Intern Med (1982) 1.53
A sorting signal for the basolateral delivery of the vesicular stomatitis virus (VSV) G protein lies in its luminal domain: analysis of the targeting of VSV G-influenza hemagglutinin chimeras. Proc Natl Acad Sci U S A (1989) 1.43
Improving self-efficacy in nursing research. Clin Nurse Spec (1996) 1.39
HM-PAO (CERETEC) SPECT brain scanning in the diagnosis of Alzheimer's disease. J Am Geriatr Soc (1997) 1.38
Factors associated with long-term institutionalization of older people with dementia: data from the Canadian Study of Health and Aging. J Gerontol A Biol Sci Med Sci (2001) 1.35
Predictors of five-year mortality in older Canadians: the Canadian Study of Health and Aging. J Am Geriatr Soc (1999) 1.32
Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology (2001) 1.31
The Canadian Neurological Scale: a preliminary study in acute stroke. Stroke (1986) 1.29
Reliability, validity, and applicability of the Quebec User Evaluation of Satisfaction with assistive Technology (QUEST 2.0) for adults with multiple sclerosis. Disabil Rehabil (2002) 1.22
Social networks and self-rated health in two French-speaking Canadian community dwelling populations over 65. Soc Sci Med (2004) 1.19
Pyogenic vertebral osteomyelitis: analysis of 20 cases and review. Clin Infect Dis (1995) 1.17
Undetected dementia in community-dwelling older people: the Canadian Study of Health and Aging. J Am Geriatr Soc (2000) 1.17
Multicenter evaluation of the Abbott LCx Mycobacterium tuberculosis ligase chain reaction assay. J Clin Microbiol (1999) 1.10
Nonpolarized secretion of truncated forms of the influenza hemagglutinin and the vesicular stomatitus virus G protein from MDCK cells. Proc Natl Acad Sci U S A (1987) 1.07
The Canadian Study of Health and Aging: organizational lessons from a national, multicenter, epidemiologic study. Int Psychogeriatr (2001) 1.06
Laboratory cross-contamination of Mycobacterium tuberculosis: an investigation and analysis of causes and consequences. Intern Med J (2002) 1.04
Long-term continuous use of benzodiazepines by older adults in Quebec: prevalence, incidence and risk factors. J Am Geriatr Soc (2000) 1.03
Observer variation in the classification of mammographic parenchymal patterns. J Chronic Dis (1986) 1.01
Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Ann Neurol (1994) 1.01
C-microtubules in isolated mitotic spindles. J Cell Sci (1971) 1.01
Outcome and complications of temporary haemodialysis catheters. Nephrol Dial Transplant (1999) 0.99
Multi-drug resistant Pseudomonas aeruginosa outbreak in a burns unit--an infection control study. Burns (2001) 0.98
Validation of a French version of an informant-based questionnaire as a screening test for Alzheimer's disease. Br J Psychiatry (1995) 0.97
Environmental risk factors in multiple sclerosis. Acta Neurol Scand Suppl (2008) 0.97
E test susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and the novel agents moxifloxacin, gatifloxacin, and linezolid. Eur J Clin Microbiol Infect Dis (2002) 0.95
Organic solvents and multiple sclerosis: a synthesis of the current evidence. Epidemiology (1996) 0.94
Development of simple cognitive function measures in a community dwelling population of elderly in Spain. Int J Geriatr Psychiatry (2000) 0.93
Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. Brain (1996) 0.92
Transcription factor phosphorylation by the DNA-dependent protein kinase. Biochem Soc Trans (1993) 0.91
Clinical experience of cancer specialists and geriatricians involved in cancer care of older patients: A qualitative study. Crit Rev Oncol Hematol (2009) 0.91
Evaluation of E test as a rapid method for determining MICs for nutritionally variant streptococci. J Clin Microbiol (1994) 0.90
Disseminated mucormycosis due to Saksenaea vasiformis in an immunocompetent adult. Clin Infect Dis (2000) 0.90
Hemostatic markers in acute transient ischemic attacks. Stroke (1994) 0.90
Does frailty predict hospitalization, emergency department visits, and visits to the general practitioner in older newly-diagnosed cancer patients? Results of a prospective pilot study. Crit Rev Oncol Hematol (2009) 0.90
Candidaemia in an Australian teaching hospital: relationship to central line and TPN use. J Infect (1998) 0.89
Review of outcome measurement instruments in Alzheimer's disease drug trials: psychometric properties of functional and quality of life scales. J Geriatr Psychiatry Neurol (2000) 0.88
Point-of-care urinary pneumococcal antigen test in the emergency department for community acquired pneumonia. Emerg Med J (2008) 0.88
Consensus guidelines for the treatment of invasive mould infections in haematological malignancy and haemopoietic stem cell transplantation, 2014. Intern Med J (2014) 0.88
Phosphorylation of transcription factor Sp1 by the DNA-dependent protein kinase. Adv Second Messenger Phosphoprotein Res (1993) 0.88
Multiple sclerosis and varicella zoster virus infection: a review. Epidemiol Infect (2001) 0.88
Consensus guidelines for the use of empiric and diagnostic-driven antifungal treatment strategies in haematological malignancy, 2014. Intern Med J (2014) 0.88
Validation of the non-motor symptoms questionnaire (NMS-Quest). Parkinsonism Relat Disord (2011) 0.87
Tuberculous cranial pachymeningitis. Neurology (2007) 0.87
Case report. Successful treatment of cutaneous Paecilomyces lilacinus infection with oral itraconazole in an immune competent host. Mycoses (2001) 0.87
Human herpes virus 6 and multiple sclerosis. Acta Neurol Scand (2002) 0.87
Diagnosing pneumococcal pneumonia. Lancet (1987) 0.85
Hemostatic markers in patients at risk of cerebral ischemia. Stroke (2000) 0.85
Review of outcome measurement instruments in Alzheimer's disease drug trials: psychometric properties of global scales. J Geriatr Psychiatry Neurol (2000) 0.85
Quality of life during the course of cancer treatment in older newly diagnosed patients. Results of a prospective pilot study. Ann Oncol (2010) 0.85
A recommended method for obtaining the age at onset of dementia from the CSHA database. Int Psychogeriatr (2001) 0.85
Emerging drug resistance and vaccination for typhoid fever. JAMA (1998) 0.84
Etoposide-induced cell cycle delay and arrest-dependent modulation of DNA topoisomerase II in small-cell lung cancer cells. Br J Cancer (1994) 0.84
Observer variation in the interpretation of xeromammograms. J Natl Cancer Inst (1982) 0.84
Native valve endocarditis and vertebral osteomyelitis caused by Staphylococcus epidermidis. Med J Aust (1992) 0.83
Review of outcome measurement instruments in Alzheimer's disease drug trials: psychometric properties of behavior and mood scales. J Geriatr Psychiatry Neurol (2000) 0.82
The Etest for antimicrobial susceptibility testing of Bartonella henselae. J Antimicrob Chemother (1996) 0.81
Is high socioeconomic status a risk factor for multiple sclerosis? A systematic review. Eur J Neurol (2014) 0.81
A questionnaire for multinational case-control studies of environmental risk factors in multiple sclerosis (EnvIMS-Q). Acta Neurol Scand Suppl (2012) 0.80
Fusidic acid in bone and joint infections. Int J Antimicrob Agents (1999) 0.80
A Markov model of the natural history of multiple sclerosis. Neuroepidemiology (1985) 0.80
Persistent Rhodococcus equi infection in a renal transplant patient: case report and review of the literature. Transpl Infect Dis (2012) 0.80
Reliable individual change scores on the 3MS in older persons with dementia: results from the Canadian Study of Health and Aging. Int Psychogeriatr (2001) 0.79
Do patient factors alter the relationship between physician characteristics and use of long-acting benzodiazepines? J Clin Epidemiol (2000) 0.78
New screening medium for detection and identification of methicillin/oxacillin-resistant Staphylococcus aureus for nosocomial surveillance. Eur J Clin Microbiol Infect Dis (2002) 0.78
The role of viruses and atypical organisms in the pathogenesis of adult pneumonia in Papua New Guinea. P N G Med J (1991) 0.78
Treatment comfort of adult neurologists in childhood onset conditions. Can J Neurol Sci (2012) 0.77
Vibrio damsela wound infections in Australia. Med J Aust (1989) 0.77
Comparison of two commercial enzyme immunoassays with cytotoxicity assay and culture for the diagnosis of Clostridium difficile related diarrhea. Pathology (1996) 0.77
Statistics for investigation of multimodal MR imaging data and an application to multiple sclerosis patients. NMR Biomed (1996) 0.77
Drug-resistant Streptococcus pneumoniae: the beginning of the end for many antibiotics? Med J Aust (1996) 0.77
Restless legs syndrome outside the blood-brain barrier--exacerbation by domperidone in Parkinson's disease. Parkinsonism Relat Disord (2012) 0.76
Elements of mobility as predictors of survival in elderly patients with dementia: findings from the Canadian Study of Health and Aging. Chronic Dis Can (2000) 0.76
High daily doses of benzodiazepines among Quebec seniors: prevalence and correlates. BMC Geriatr (2001) 0.76
Interobserver variability in the interpretation of contrast venography, technetium-99m red blood cell venography and impedance plethysmography for deep vein thrombosis. Can Assoc Radiol J (1990) 0.76
Staphylococcal bacteraemia: the hospital or the home? A review of Staphylococcus aureus bacteraemia at Concord Hospital in 1993. Aust N Z J Med (1998) 0.75
Latent periods in multiple sclerosis. Neuroepidemiology (1996) 0.75
Streptococcus pneumoniae serotyping. Pathology (1989) 0.75
Pseudomonas fluorescens pseudobacteraemia. Med J Aust (1992) 0.75
Trimethoprim-induced aseptic meningitis and uveitis. Lancet (1997) 0.75
Antimicrobial susceptibility of anaerobic bacteria in Australia. J Antimicrob Chemother (1992) 0.75
Review of outcome measurement instruments in Alzheimer's disease drug trials: introduction. J Geriatr Psychiatry Neurol (2000) 0.75
Chronic meningococcaemia. Aust N Z J Med (1998) 0.75
Increasing ampicillin resistance among non-invasive Haemophilus influenzae isolates. Med J Aust (1998) 0.75
[Epidemiology of breast feeding among mothers in a region of Montreal]. Union Med Can (1980) 0.75
A survey of medical staff attitudes to an antibiotic approval and stewardship programme. Intern Med J (2009) 0.75
Fatal hepatitis B virus infection with fibrosing cholestatic hepatitis following renal transplantation. Nephrol Dial Transplant (1998) 0.75
Technetium-99m red blood cell venography in patients with clinically suspected deep vein thrombosis: a prospective study. J Nucl Med (1988) 0.75
Optimal phenotypic testing of AmpC beta-lactamases using boronic acid solutions. Eur J Clin Microbiol Infect Dis (2011) 0.75